MX2009012540A - Implante de hidrogel para detectar metabolitos en tejido corporal. - Google Patents

Implante de hidrogel para detectar metabolitos en tejido corporal.

Info

Publication number
MX2009012540A
MX2009012540A MX2009012540A MX2009012540A MX2009012540A MX 2009012540 A MX2009012540 A MX 2009012540A MX 2009012540 A MX2009012540 A MX 2009012540A MX 2009012540 A MX2009012540 A MX 2009012540A MX 2009012540 A MX2009012540 A MX 2009012540A
Authority
MX
Mexico
Prior art keywords
sensor
implant
body tissue
hydrogel
matrix
Prior art date
Application number
MX2009012540A
Other languages
English (en)
Inventor
Peter Herbrechtsmeier
Achim Mueller
Original Assignee
Eyesense Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyesense Ag filed Critical Eyesense Ag
Publication of MX2009012540A publication Critical patent/MX2009012540A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/7703—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
    • G01N2021/7706—Reagent provision
    • G01N2021/773—Porous polymer jacket; Polymer matrix with indicator
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N2021/7769—Measurement method of reaction-produced change in sensor
    • G01N2021/7786—Fluorescence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Plasma & Fusion (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Un implante (110) es mostrado para detectar al menos un analito (126) en un fluido corporal, particularmente agua ocular. El implante (110) es diseñado para ser implantado en una capa de tejido y/o una cámara ocular de un paciente y comprende una matriz de hidrogel (110) que contiene al menos un hidrogel (114). El implante posteriormente comprende partículas de sensor (116) que son dispersadas en la matriz de hidrogel (110). Las partículas del sensor (116) tienen al menos una matriz de sensor (120) con un material de matriz de sensor (122) así como al menos un material de sensor (124).
MX2009012540A 2007-05-24 2008-05-23 Implante de hidrogel para detectar metabolitos en tejido corporal. MX2009012540A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007024642A DE102007024642A1 (de) 2007-05-24 2007-05-24 Hydrogel-Implantat für Sensorik von Metaboliten am Auge
US92466907P 2007-05-25 2007-05-25
PCT/EP2008/056364 WO2008142158A2 (de) 2007-05-24 2008-05-23 Hydrogel-implantat für sensorik von metaboliten in körpergewebe

Publications (1)

Publication Number Publication Date
MX2009012540A true MX2009012540A (es) 2010-02-12

Family

ID=39877224

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012540A MX2009012540A (es) 2007-05-24 2008-05-23 Implante de hidrogel para detectar metabolitos en tejido corporal.

Country Status (12)

Country Link
US (1) US8647271B2 (es)
EP (2) EP2842481B1 (es)
KR (1) KR101510488B1 (es)
CN (1) CN101707931B (es)
AU (1) AU2008252936B2 (es)
CA (1) CA2688011C (es)
DE (1) DE102007024642A1 (es)
ES (1) ES2643055T3 (es)
HK (1) HK1143727A1 (es)
MX (1) MX2009012540A (es)
TW (1) TWI459977B (es)
WO (1) WO2008142158A2 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502006002076D1 (de) * 2006-07-24 2008-12-24 Eyesense Ag Vorrichtung zur Messung eines Analyten in einer Augenflüssigkeit
US9517023B2 (en) 2009-06-01 2016-12-13 Profusa, Inc. Method and system for directing a localized biological response to an implant
US9409013B2 (en) 2009-10-20 2016-08-09 Nyxoah SA Method for controlling energy delivery as a function of degree of coupling
US9415215B2 (en) 2009-10-20 2016-08-16 Nyxoah SA Methods for treatment of sleep apnea
US10010272B2 (en) 2010-05-27 2018-07-03 Profusa, Inc. Tissue-integrating electronic apparatus
AU2011311889C1 (en) * 2010-10-06 2015-04-16 Profusa, Inc. Tissue-integrating sensors
CA2820841C (en) * 2010-12-17 2018-10-23 Eyesense Ag Competitive biosensor having elevated sensitivity
AU2011344244B2 (en) * 2010-12-17 2016-03-17 Eyesense Ag Use of hydrogels for biosensors having elevated sensitivity
CN105879221B (zh) 2011-09-30 2019-08-16 人与科学股份有限公司 用于影响血压的高血压治疗植入单元
DE102012201892A1 (de) * 2012-02-09 2013-08-14 Robert Bosch Gmbh Bestimmung des Blutzuckerspiegels eines Patienten unter Verwendung eines implantierbaren Sensors und eines elektrischen Funktionspflasters
WO2013148957A1 (en) 2012-03-28 2013-10-03 Becton, Dickinson And Company Hydrogel adhesion to molded polymers
US9084530B2 (en) 2012-04-12 2015-07-21 Elwha Llc Computational methods and systems for reporting information regarding appurtenances to wound dressings
US10158928B2 (en) 2012-04-12 2018-12-18 Elwha Llc Appurtenances for reporting information regarding wound dressings
US10265219B2 (en) 2012-04-12 2019-04-23 Elwha Llc Wound dressing monitoring systems including appurtenances for wound dressings
US10130518B2 (en) 2012-04-12 2018-11-20 Elwha Llc Appurtenances including sensors for reporting information regarding wound dressings
US10226212B2 (en) 2012-04-12 2019-03-12 Elwha Llc Appurtenances to cavity wound dressings
US9024751B2 (en) 2012-04-12 2015-05-05 Elwha Llc Dormant to active appurtenances for reporting information regarding wound dressings
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
CN108013881B (zh) 2013-03-14 2021-06-15 普罗菲尤萨股份有限公司 用于校正光学信号的方法和装置
US9161712B2 (en) 2013-03-26 2015-10-20 Google Inc. Systems and methods for encapsulating electronics in a mountable device
CA2913474C (en) 2013-06-06 2023-04-18 William A. Mcmillan Apparatus and methods for detecting optical signals from implanted sensors
WO2017100680A1 (en) * 2015-12-09 2017-06-15 The Texas A&M University System Implantable biosensors
US9983185B2 (en) * 2016-02-01 2018-05-29 City University Of Hong Kong Chemosensing hydrogel for the detection of biogenic amines
EP3503804A1 (en) * 2016-08-26 2019-07-03 Cardiac Pacemakers, Inc. Systems and methods for determining an abnormal glycemic event using surrogates for glucose
WO2018119400A1 (en) 2016-12-22 2018-06-28 Profusa, Inc. System and single-channel luminescent sensor for and method of determining analyte value
CN110678117A (zh) * 2017-03-01 2020-01-10 梅特罗诺姆保健公司 分析物传感器和制造分析物传感器的方法
CN112218908B (zh) 2018-01-18 2023-09-29 Hy2保健公司 用于降低选定生物分子的生物利用度的多孔亲和水凝胶颗粒
CN111543961B (zh) * 2020-05-11 2021-03-09 清华大学 无线柔性贴片式温度传感器及其制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180308A (en) * 1972-10-02 1979-12-25 Syntex (Usa) Inc. Contact lens
US5127901A (en) 1990-05-18 1992-07-07 Odrich Ronald B Implant with subconjunctival arch
US5545423A (en) * 1991-11-25 1996-08-13 Vivorx, Inc. Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials
US5178635A (en) 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US5404951A (en) * 1993-07-07 1995-04-11 Atlantic Richfield Company Well treatment with artificial matrix and gel composition
DK0637490T3 (da) 1993-07-19 1999-10-11 Novartis Erfind Verwalt Gmbh Fremgangsmåde og apparat til fremstilling af kontaktlinser
TW272976B (es) * 1993-08-06 1996-03-21 Ciba Geigy Ag
AU4438696A (en) 1995-02-03 1996-08-21 Novartis Ag Crosslinked polymers
US5705780A (en) * 1995-06-02 1998-01-06 Howmedica Inc. Dehydration of hydrogels
US6011984A (en) * 1995-11-22 2000-01-04 Minimed Inc. Detection of biological molecules using chemical amplification and optical sensors
US6451871B1 (en) 1998-11-25 2002-09-17 Novartis Ag Methods of modifying surface characteristics
EP1647270B1 (de) 1998-03-19 2009-06-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zum Aufbringen mehrerer Schichten von Beschichtungssubstanzen auf Templatpartikel
EP1064088B1 (en) 1998-03-19 2002-12-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
ATE377449T1 (de) * 1998-07-15 2007-11-15 Max Planck Gesellschaft Polyelektrolythüllen auf biologischen templaten
US6485703B1 (en) * 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
US6259518B1 (en) * 1999-08-10 2001-07-10 Novartis Ag Wetcell device for inspection
AU1623300A (en) * 1998-11-13 2000-06-05 Sensor Technologies, Inc. Monodisperse preparations useful with implanted devices
US6329485B1 (en) * 1998-12-11 2001-12-11 Bausch & Lomb Incorporated High refractive index hydrogel compositions for ophthalmic implants
JP4970678B2 (ja) 1999-06-10 2012-07-11 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ 多層コーティングによる結晶のカプセル化
HU226183B1 (en) 1999-08-26 2008-06-30 Novartis Ag Ophthalmic lens and sensor system for measuring the concentration of an analyte in an ocular fluid
US6416777B1 (en) 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
DE10001172A1 (de) 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
AR027348A1 (es) 2000-02-04 2003-03-26 Novartis Ag Proceso para recubrir una superficie
FR2810552B1 (fr) * 2000-06-26 2004-11-19 Univ Paris Curie Polymere biocompatible a structure tridimensionnelle a cellules communicantes, procede de preparation et application en medecine et en chirurgie
ATE295156T1 (de) 2000-08-28 2005-05-15 Max Planck Gesellschaft Mehrlagige polyelektrolytkapseln mit gesteuerter und verzögerter freisetzung
WO2002087429A1 (en) 2001-04-27 2002-11-07 Novartis Ag Apparatus for measuring blood glucose concentrations
GB0116853D0 (en) * 2001-07-10 2001-09-05 Torsana Diabetes Diagnostics A Optical sensor containing particles for in SITU measurement of analytes
CA2446741C (en) 2001-07-23 2009-09-29 Alcon, Inc. Ophthalmic drug delivery device
US6719699B2 (en) * 2002-02-07 2004-04-13 Sonotech, Inc. Adhesive hydrophilic membranes as couplants in ultrasound imaging applications
DE50308422D1 (de) * 2002-08-02 2007-11-29 Capsulution Nanoscience Ag Farbkodierte layer-by-layer mikrokapseln als kombinatorische analysebibliotheken und als spezifische optische sensoren
US6896926B2 (en) 2002-09-11 2005-05-24 Novartis Ag Method for applying an LbL coating onto a medical device
US6926965B2 (en) 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US20040180391A1 (en) * 2002-10-11 2004-09-16 Miklos Gratzl Sliver type autonomous biosensors
US8216854B2 (en) * 2003-01-07 2012-07-10 Biotex, Inc. Device and method for measuring analytes
WO2004064629A1 (en) 2003-01-21 2004-08-05 Ehrfeld Miktotechnik Ag Sensor system for detecting analytes in tear fluid
US20050095174A1 (en) * 2003-10-31 2005-05-05 Wolf David E. Semipermeable sensors for detecting analyte
DE102004013637A1 (de) * 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
WO2006104498A2 (en) * 2004-04-20 2006-10-05 University Of Rochester Hydrogel-supported porous semiconductor devices
MX2008001762A (es) * 2005-08-11 2008-04-07 Coopervision Inc Lentes de contacto y metodos para reducir presion de la conjuntiva en usuarios de lentes de contacto.
US7704704B2 (en) * 2005-09-28 2010-04-27 The Texas A&M University System Implantable system for glucose monitoring using fluorescence quenching
US20070122362A1 (en) * 2005-11-26 2007-05-31 Giniger Martin S Hydrogel sheets and shapes for oral care
US8126554B2 (en) * 2006-05-17 2012-02-28 Cardiac Pacemakers, Inc. Implantable medical device with chemical sensor and related methods
US7572841B2 (en) * 2006-06-15 2009-08-11 Coopervision International Holding Company, Lp Wettable silicone hydrogel contact lenses and related compositions and methods
DE102007003341B4 (de) * 2007-01-17 2018-01-04 Eyesense Ag Okularsensor und Messsystem zum Nachweis eines Analyten in einer Augenflüssigkeit

Also Published As

Publication number Publication date
US8647271B2 (en) 2014-02-11
TW200911305A (en) 2009-03-16
AU2008252936A1 (en) 2008-11-27
US20100331634A1 (en) 2010-12-30
DE102007024642A1 (de) 2008-11-27
WO2008142158A3 (de) 2009-05-28
EP2842481A1 (de) 2015-03-04
CN101707931B (zh) 2012-12-05
CN101707931A (zh) 2010-05-12
AU2008252936B2 (en) 2013-11-07
ES2643055T3 (es) 2017-11-21
CA2688011C (en) 2016-08-30
TWI459977B (zh) 2014-11-11
CA2688011A1 (en) 2008-11-27
KR20100033382A (ko) 2010-03-29
EP2842481B1 (de) 2017-07-12
HK1143727A1 (en) 2011-01-14
WO2008142158A2 (de) 2008-11-27
EP2164384A2 (de) 2010-03-24
KR101510488B1 (ko) 2015-04-08

Similar Documents

Publication Publication Date Title
MX2009012540A (es) Implante de hidrogel para detectar metabolitos en tejido corporal.
EA201000953A1 (ru) Медицинский электрод, пучок электродов и массив из пучков электродов
WO2007146489A3 (en) Device for lymphatic system monitoring
WO2007053814A8 (en) Implantation of medical device with measurement of body surface potential
GB201007235D0 (en) Taz/wwtr1 for diagnosis and treatment of cancer
WO2007117611A3 (en) Enhanced t cell receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with crohn's disease
WO2007041293A3 (en) Microelectrode systems for neuro-stimulation and neuro-sensing and microchip packaging and related methods
WO2008122596A3 (en) Curable therapeutic implant composition
WO2010062654A3 (en) Device and method for the study of cell and tissue function
HRP20130618T1 (en) Methods of using mirna for detection of in vivo cell death
WO2005079257A3 (en) Biointerface with macro- and micro- architecture
WO2007110867A8 (en) Implantable sensor
EP2056708A4 (en) MICROFABRICATED IMPLANTABLE RADIO PRESSURE SENSOR FOR USE IN BIOMEDICAL APPLICATIONS AND PRESSURE MEASUREMENT AND SENSOR IMPLANTATION METHOD
WO2006055547A3 (en) Instrumented orthopedic and other medical implants
EP2382951A3 (en) Apparatus for adjustment and sensing of gastric band pressure
WO2009036105A3 (en) Infusion therapy sensor system
WO2008082730A3 (en) Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors
WO2008018642A3 (en) Genes and polypeptides relating to breast cancers
WO2008107724A3 (en) Stabilisation of biological cell markers
WO2008070663A3 (en) Companion diagnostic assays for cancer therapy
EP2455755A3 (en) Proteaoglycan-4 as marker for chronic renal failure
WO2008133196A1 (ja) 再生医療用材料
WO2011151815A3 (en) Implant with body and at least one flute
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
ATE507768T1 (de) Implantationsvorrichtung für metabolitsensoren

Legal Events

Date Code Title Description
FG Grant or registration